Susceptibility to antimicrobials of bacterial belonging to Nocardia genus and treatment of nocardiosis

Antibiotiques

Volumn 3, Issue 2, 2001, Pages 104-110

  Laurent, F ^a   Casoli, E ^a   Boiron, P ^a  

^a HOSPICES CIVILS DE LYON   (France)

Author keywords

Antibiotherapy; In vitro; Nocardia; Nocardiosis; Susceptibility; Treatment

Indexed keywords

AMIKACIN; AMINOGLYCOSIDE ANTIBIOTIC AGENT; AMOXICILLIN PLUS CLAVULANIC ACID; AMPICILLIN; ANTIBIOTIC AGENT; BETA LACTAM ANTIBIOTIC; BETA LACTAMASE; CEFOTAXIME; CEFTRIAXONE; CIPROFLOXACIN; COTRIMOXAZOLE; ERYTHROMYCIN; IMIPENEM; MINOCYCLINE; PIPERACILLIN PLUS TAZOBACTAM; QUINOLINE DERIVED ANTIINFECTIVE AGENT; SULFANILAMIDE; TRIMETHOPRIM; UNACINE;

ANIMAL MODEL; ANTIBIOTIC PROPHYLAXIS; ANTIBIOTIC SENSITIVITY; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; HUMAN; IN VITRO STUDY; INCIDENCE; NOCARDIA; NOCARDIOSIS; NONHUMAN; PATHOLOGY;

EID: 0034987014     PISSN: 12945501     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (61)

1. The ecology of Nocardioform actinomycetes
2. Antibiotic sensitivity of some nocardioform bacteria and its value as a criterion for taxonomy
3. Review of nocardial infections in France 1987 to 1990
4. Human nocardiosis in northern Italy from 1982 to 1992
5. The medically important aerobic actinomycetes : Epidemiology and microbiology
6. Nocardial infections in the immunocompromised host : A detailed study in a defined population
7. Nocardiosis
8. Nocardial infections in the United States, 1972-1974
9. Mycétome
10. Cutaneous nocardiosis. Case reports and review
11. Infection with Nocardia species in Queensland. A review of 102 clinical, isolates
12. Factors affecting survival in nocardiosis
13. Nocardia mastitidis in cattle : Clinical observations and diagnosis in 7 particular cases
14. Nocardia crassotreae sp. nov., the causal agent of nocardiosis in Pacific oysters
15. Nocardial infections of animals in New Zeland 1976 to 1978
16. Management of Nocardia infections
17. Therapy of pulmonary nocardiosis in immunocompromised mice
18. Comparaison of agar dilution, broth microdilution, disk diffusion, E-Test, and BACTEC radiometric methods for antimicrobial susceptibility testing of clinical isolates of the Nocardia asteroides complex
19. In vitro susceptibility testing of clinical isolates of Nocardia
20. Disk diffusion susceptibility testing of Nocardia species
21. Beta-lactamase production and resistance to beta-lactam antibiotics in Nocardia
22. A method for determining in-vitro drug susceptibilities of some Nocardiae and Actinomadurae : Results with 17 antimicrobial agents
23. Susceptibility of Nocardia asteroides to 45 antimicrobial agents in vitro
24. Susceptibility of Nocardia species to modern antimicrobial agents
25. In vitro susceptibility of Nocardia asteroides to 25 antimicrobial agents
26. Susceptibility of Nocardia asteroides to 46 antibiotics, including 22 beta-lactams
27. Antimicrobial susceptibility of Nocardia species
28. Differences among Nocardia spp. in susceptibility to aminoglycosides and beta-lactam antibiotics and their potential use in taxonomy
29. Antimicrobial susceptibility patterns of Nocardia asteroides
30. Cefotaxime-resistant Nocardia asteroides strains are isolates of the controversial species Nocardia farcinica
31. Clinical and laboratory features of Nocardia nova
32. DNA amplification and restriction endonuclease analysis for differentiation of 12 species and taxa of Nocardia, including recognition of four new taxa within the Nocardia asteroides complex
33. Rapid identification of clinically significant species and taxa of aerobic actinomycetes, including Actinomadura, Gordona, Nocardia, Rhodococcus, Streptomyces, and Tsukanurella isolates, by DNA endonuclease analysis
34. Antimicrobial susceptibilities of regional pathogenic strains of Nocardia isolated from mycetomas
35. Susceptibility of recently isolated bacteria to amikacin in vitro : Comparisons with four other aminoglycoside antibiotics
36. Comparison of species distribution and antimicrobial susceptibility of aerobic actinomycetes from clinical specimens
37. Activity of antimicrobial drugs evaluated by agar dilution and radiometric methods against strains of Nocardia asteroides isolated in Italy from immunocompromised patients
38. Identification and antibiotic susceptibility of Nocardia farcinica and Nocardia nova in the UK
39. In vitro susceptibility of Nocardia asteroides to 21 beta-lactam antibiotics, in combination with three beta-lactamase inhibitors, and its relationship to the beta-lactamase content
40. Distribution and characterization of beta-lactamases of mycobacteria and related organisms
41. Acquired resistance of Nocardia brasiliensis to clavulanic acid related to a change in β-lactamase following therapy with amoxicillin-clavulanic acid
42. Beta-lactam resistance in Nocardia brasiliensis is mediated by beta-lactamase and reversed in the presence of clavulanic acid
43. Recurrent Nocardia pneumonia in an adult with chronic granulomatous disease
44. Non-inducible, mainly cell-associated beta-lactamase from Nocardia asteroides strain 108
45. Partial characterization of Nocardia farcinica beta-lactamases
46. Biochemical-genetic analysis and distribution of FAR-1, a class A beta-lactamase from Nocardia farcinica
47. Cloning and biochemical analysis of AST-1, a class A lactamase from a clinical Nocardia asteroides sensu stricto isolate
48. The structure of β-lactamases
49. Nocardiosis
50. Nocardia pseudobrasiliensis sp. nov., a new species of Nocardia which groups bacterial strains previously identified as Nocardia brasiliensis and associated with invasive diseases
51. Differentiation between genera Rhodococcus and Nocardia by susceptibility testing to kanamycin and some other antituberculous agents
52. New Nocardia taxons among isolates of Nocardia brasiliensis associated with invasive disease
53. Characterisation of Nocardia nova
54. Diagnostic and therapeutic considerations in Nocardia asteroides infection
55. Trimethoprim-sulfamethoxazole therapy for Nocardia infections
56. Use of trimethoprim-sulfamethoxazole for treatment of infections due to Nocardia
57. Susceptibility of Nocardia asteroides to various antibiotics, including newer beta-lactams, trimethoprim-sulfamethoxazole, amikacin, and N-formimidoyl thienamycin
58. Synergism of imipenem and amikacin in combination with other antibiotics against Nocardia asteroides
59. Antimicrobial synergism in the therapy of experimental cerebral nocardiosis